209 related articles for article (PubMed ID: 30019516)
1. Evaluation of Quality of Life Using EORTC QLQ-BM22 in Patients with Bone Metastases after Treatment with Magnetic Resonance Guided Focused Ultrasound.
Chen ZQ; Wang CR; Ma XJ; Sun W; Shen JK; Sun MX; Fu ZZ; Hua YQ; Cai ZD
Orthop Surg; 2018 Aug; 10(3):264-271. PubMed ID: 30019516
[TBL] [Abstract][Full Text] [Related]
2. EORTC QLQ-BM22 quality of life evaluation and pain outcome in patients with bone metastases from breast cancer treated with zoledronic acid.
Yeh DC; Chen DR; Chao TY; Chen SC; Wang HC; Rau KM; Feng YH; Chang YC; Lee KD; Ou-Yang F; Kuo WH; Chang KJ; Lin YC; Tseng LM; Hou MF
In Vivo; 2014; 28(5):1001-4. PubMed ID: 25189922
[TBL] [Abstract][Full Text] [Related]
3. Quality of life after palliative radiation therapy for patients with painful bone metastases: results of an international study validating the EORTC QLQ-BM22.
Zeng L; Chow E; Bedard G; Zhang L; Fairchild A; Vassiliou V; Alm El-Din MA; Jesus-Garcia R; Kumar A; Forges F; Tseng LM; Hou MF; Chie WC; Bottomley A
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e337-42. PubMed ID: 22763028
[TBL] [Abstract][Full Text] [Related]
4. A prospective study validating the EORTC QLQ-BM22 bone metastases module in patients with painful bone metastases undergoing palliative radiotherapy.
Raman S; Ding K; Chow E; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JS; Dennis K; DeAngelis C; Wong RK; Zhu L; Brundage M
Radiother Oncol; 2016 May; 119(2):208-12. PubMed ID: 27157890
[TBL] [Abstract][Full Text] [Related]
5. [Magnetic resonance guided focused ultrasound surgery for pain palliation of bone metastases: early experience of clinical application in China].
Gu J; Wang H; Tang N; Hua Y; Yang H; Qiu Y; Ge R; Zhou Y; Wang W; Zhang G
Zhonghua Yi Xue Za Zhi; 2015 Nov; 95(41):3328-32. PubMed ID: 26812970
[TBL] [Abstract][Full Text] [Related]
6. Quality of life in responders after palliative radiation therapy for painful bone metastases using EORTC QLQ-C30 and EORTC QLQ-BM22: results of a Brazilian cohort.
Mendez LC; Raman S; Wan BA; da Silva JLP; Moraes FY; Lima KMLB; Silva MF; Diz MDPE; Chow E; Marta GN
Ann Palliat Med; 2017 Aug; 6(Suppl 1):S65-S70. PubMed ID: 28595442
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Quality of Life Outcomes Following Palliative Treatment of Bone Metastases with Magnetic Resonance-guided High Intensity Focused Ultrasound: An International Multicentre Study.
Harding D; Giles SL; Brown MRD; Ter Haar GR; van den Bosch M; Bartels LW; Kim YS; Deppe M; deSouza NM
Clin Oncol (R Coll Radiol); 2018 Apr; 30(4):233-242. PubMed ID: 29317145
[TBL] [Abstract][Full Text] [Related]
8. EORTC QLQ-BM22 and QLQ-C30 quality of life scores in patients with painful bone metastases of prostate cancer treated with strontium-89 radionuclide therapy.
Kurosaka S; Satoh T; Chow E; Asano Y; Tabata K; Kimura M; Tsumura H; Matsumoto K; Ishiyama H; Inoue Y; Hayakawa K; Baba S
Ann Nucl Med; 2012 Jul; 26(6):485-91. PubMed ID: 22477263
[TBL] [Abstract][Full Text] [Related]
9. Minimal clinically important differences in the EORTC QLQ-BM22 and EORTC QLQ-C15-PAL modules in patients with bone metastases undergoing palliative radiotherapy.
Raman S; Ding K; Chow E; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; DeAngelis C; Wong RKS; Zhu L; Brundage M
Qual Life Res; 2016 Oct; 25(10):2535-2541. PubMed ID: 27138964
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the EORTC QLQ-BM22 and the FACT-BP for assessment of quality of life in cancer patients with bone metastases.
Popovic M; Nguyen J; Chen E; Di Giovanni J; Zeng L; Chow E
Expert Rev Pharmacoecon Outcomes Res; 2012 Apr; 12(2):213-9. PubMed ID: 22458622
[TBL] [Abstract][Full Text] [Related]
11. Palliative treatment of painful bone metastases with MR imaging--guided focused ultrasound.
Gianfelice D; Gupta C; Kucharczyk W; Bret P; Havill D; Clemons M
Radiology; 2008 Oct; 249(1):355-63. PubMed ID: 18695209
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the EORTC QLQ-BM22 and the BOMET-QOL quality of life questionnaires in patients with bone metastases.
Bedard G; Zeng L; Poon M; Lam H; Lauzon N; Chow E
Asia Pac J Clin Oncol; 2014 Jun; 10(2):118-23. PubMed ID: 23551978
[TBL] [Abstract][Full Text] [Related]
13. Classification of painful bone metastases as mild, moderate, or severe using both EORTC QLQ-C15-PAL and EORTC QLQ-BM22.
McDonald R; Ding K; Chow E; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar R; Mahmud A; Fairchild A; Wilson CF; Wu JS; Dennis K; DeAngelis C; Wong RK; Zhu L; Brundage M
Support Care Cancer; 2016 Dec; 24(12):4871-4878. PubMed ID: 27465049
[TBL] [Abstract][Full Text] [Related]
14. An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases.
Zeng L; Chow E; Zhang L; Tseng LM; Hou MF; Fairchild A; Vassiliou V; Jesus-Garcia R; Alm El-Din MA; Kumar A; Forges F; Chie WC; Bedard G; Bottomley A
Support Care Cancer; 2012 Dec; 20(12):3307-13. PubMed ID: 22562607
[TBL] [Abstract][Full Text] [Related]
15. A brief instrument to measure health-related quality-of-life in patients with bone metastasis: validation of the German version of Bone Metastases Quality-of-Life-10 (BOMET-QoL-10).
Marschner N; Wilke J; Reschke D; Kaiser F; Schmoor C; Grugel R; Boller E
J Med Econ; 2018 Sep; 21(9):920-929. PubMed ID: 29874105
[TBL] [Abstract][Full Text] [Related]
16. Pain palliation in patients with bone metastases using magnetic resonance-guided focused ultrasound with conformal bone system: a preliminary report.
Joo B; Park MS; Lee SH; Choi HJ; Lim ST; Rha SY; Rachmilevitch I; Lee YH; Suh JS
Yonsei Med J; 2015 Mar; 56(2):503-9. PubMed ID: 25684002
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance-guided focused ultrasound for the treatment of painful bone metastases: role of apparent diffusion coefficient (ADC) and dynamic contrast enhanced (DCE) MRI in the assessment of clinical outcome.
Anzidei M; Napoli A; Sacconi B; Boni F; Noce V; Di Martino M; Saba L; Catalano C
Radiol Med; 2016 Dec; 121(12):905-915. PubMed ID: 27567615
[TBL] [Abstract][Full Text] [Related]
18. Understanding the EORTC QLQ-BM22, the module for patients with bone metastases.
Chow E; Bottomley A
Expert Rev Pharmacoecon Outcomes Res; 2009 Oct; 9(5):461-5. PubMed ID: 19817529
[TBL] [Abstract][Full Text] [Related]
19. Validation of the Chinese version of EORTC QLQ-BM22 in patients with bone metastases.
Zhang L; Su YJ; Chen JY; Liao ZC; Luo ZQ; Xie SM; Zhang J; Lin YS; Guo H; Sun WL; Pekbay B; Miller AR; Luo L; Rui YH; Li MH; Wang CL
Support Care Cancer; 2016 Mar; 24(3):1019-24. PubMed ID: 26245496
[TBL] [Abstract][Full Text] [Related]
20. Pain palliation in patients with bone metastases using MR-guided focused ultrasound surgery: a multicenter study.
Liberman B; Gianfelice D; Inbar Y; Beck A; Rabin T; Shabshin N; Chander G; Hengst S; Pfeffer R; Chechick A; Hanannel A; Dogadkin O; Catane R
Ann Surg Oncol; 2009 Jan; 16(1):140-6. PubMed ID: 19002530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]